Toyama, Kensuke
VA Palo Alto Health Care System · Stanford Medicine · Ehime University · Stanford University
4 papers on CoChatORCID 0000-0002-3959-4737
Most cited papers
- Verified
Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice
Lin, B., Koibuchi, N., Hasegawa, Y., Sueta, D., Toyama, K., Uekawa, K., Ma, M., Nakagawa, T., Kusaka, H., & Kim-Mitsuyama, S. (2014) · Cardiovascular Diabetology
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 423
- Verified
Exercise therapy correlates with improving renal function through modifying lipid metabolism in patients with cardiovascular disease and chronic kidney disease
Toyama, K., Sugiyama, S., Oka, H., Sumida, H., & Ogawa, H. (2010) · Journal of Cardiology
Cardiovascular and exercise physiologyChronic Kidney Disease and Diabetes
Cited by 113
- Verified
Attenuation of brain damage and cognitive impairment by direct renin inhibition in mice with chronic cerebral hypoperfusion
Dong, Y.-F., Kataoka, K., Toyama, K., Sueta, D., Koibuchi, N., Yamamoto, E., Yata, K., Tomimoto, H., Ogawa, H., & Kim-Mitsuyama, S. (2011) · Hypertension
Neurological Disease Mechanisms and TreatmentsRenin-Angiotensin System Studies
Cited by 109
- Verified
Serum microRNA‐501‐3p is a potential diagnostic tool for detecting mild cognitive impairment: Ehime genome study
Toyama, K., Spin, J. M., Tsao, P. S., Maruyama, K., Osawa, H., Mogi, M., & Takata, Y. (2023) · Journal of Neurochemistry
MicroRNA in disease regulationDementia and Cognitive Impairment Research
Cited by 9
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free